P394: Frontline combination of olverembatinib and PDT-ALL-2016 pediatric inspired protocol in Philadelphia chromosome-positive acute lymphoblastic leukemia
Home » P394: Frontline combination of olverembatinib and PDT-ALL-2016 pediatric inspired protocol in Philadelphia chromosome-positive acute lymphoblastic leukemia
2023
Zhu K, Zhang T, Wang Z, Liu Q, Zhou H. P394: Frontline combination of olverembatinib and PDT-ALL-2016 pediatric inspired protocol in Philadelphia chromosome-positive acute lymphoblastic leukemia. HemaSphere. vol. 7(suppl 3):, pp. e68180f9. [2023 EHA poster presentation]-e68180f9. [2023 EHA poster presentation], View